mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease
Title:
mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease
Author:
Hartrampf, Philipp E. Bundschuh, Ralph A. Weinzierl, Franz-Xaver Serfling, Sebastian E. Kosmala, Aleksander Seitz, Anna Katharina Kübler, Hubert Buck, Andreas K. Essler, Markus Werner, Rudolf A.
Appeared in:
European journal of nuclear medicine and molecular imaging